Pavani Garlapati
Overview
    Explore the profile of Pavani Garlapati including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              24
            
            
              Citations
              84
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Rahman E, Gayam V, Garlapati P, Patel N, Farah F, El-Hamdani A, et al.
  
  
    Arch Med Sci Atheroscler Dis
    . 2021 May;
          6:e40-e47.
    
    PMID: 34027213
  
  
          Introduction: We aimed to determine in-hospital outcomes, length of hospital stay (LOS) and resource utilization in a contemporary cohort of patients with inflammatory bowel disease (IBD) and atrial fibrillation (AFIB)....
      
2.
        
    
    Garlapati P, Rahman E, Gayam V, Chobufo M, Fatima F, Khan A, et al.
  
  
    Arch Med Sci Atheroscler Dis
    . 2020 Dec;
          5:e255-e262.
    
    PMID: 33305064
  
  
          Introduction: We aimed to determine the influence of atrial fibrillation (AF) on mortality, morbidity, length of hospital stay, and resource utilisation in patients with oesophageal variceal bleeding (OVB). Material And...
      
3.
        
    
    Gayam V, Mandal A, Ditah C, Sidhu J, Konala V, Adapa S, et al.
  
  
    South Med J
    . 2020 Nov;
          113(11):593-599.
    
    PMID: 33140114
  
  
          Objectives: We aimed to determine in-hospital outcomes, length of hospital stay, and resource utilization in a contemporary cohort of  infection (CDI) and vitamin D deficiency (VDD). Methods: The National Inpatient...
      
4.
        
    
    Garlapati P, Gajjar B, Then E, Gayam V
  
  
    Int J Clin Pract
    . 2020 Aug;
          75(2):e13633.
    
    PMID: 32741101
  
  
          Aims: We aim to determine the influence of lower gastrointestinal bleeding (LGIB) on mortality, morbidity, length of hospital stay and resource utilisation in end-stage renal disease (ESRD) patients. Material And...
      
5.
        
    
    Pan C, Gayam V, Rabinovich C, Normatov M, Fidman B, Wang D, et al.
  
  
    J Am Geriatr Soc
    . 2019 Oct;
          68(2):379-387.
    
    PMID: 31647119
  
  
          Objectives: Data on the virologic response and tolerability of direct-acting antivirals (DAAs) are lacking in older people because these individuals are underrepresented in clinical trials. This study aimed to assess...
      
6.
        
    
    Gayam V, Sidhu J, Mandal A, Garlapati P, Adapa S, Konala V, et al.
  
  
    Cureus
    . 2019 Sep;
          11(7):e5155.
    
    PMID: 31523582
  
  
          Background Pancreatic cancer (PC) is one of the common cancers in the United States (U.S.) and is associated with high mortality and morbidity. In spite of the modest improvement in...
      
7.
        
    
    Gayam V, Jegede O, Tiongson B, Mandal A, Sidhu J, Garlapati P
  
  
    Dig Dis
    . 2019 Sep;
          38(3):232-239.
    
    PMID: 31494648
  
  
          Background: The highest burden of hepatitis C virus (HCV) infection is seen in patients with psychiatric disorders who have been excluded from traditional treatments with Interferon due to treatment-emergent neuropsychiatric...
      
8.
        
    
    Gayam V, Tiongson B, Mandal A, Garlapati P, Pan C, Mohanty S
  
  
    Scand J Gastroenterol
    . 2019 May;
          54(5):646-655.
    
    PMID: 31120776
  
  
           Limited data exist evaluating the treatment outcomes with direct-acting antivirals (DAAs) in patients with drug use in the community setting. We aim to assess the treatment response of DAAs in...
      
9.
        
    
    Khalid M, Jegede O, Gayam V, Yang Y, Shrestha B, Mandal A, et al.
  
  
    Case Rep Med
    . 2019 May;
          2019:3435108.
    
    PMID: 31049067
  
  
          Clozapine is an atypical antipsychotic agent indicated in the treatment of medication-resistant schizophrenia. It is often reserved as a last line of treatment owing to the potential for serious and...
      
10.
        
    
    Gayam V, Mandal A, Garlapati P, Khalid M, Shrestha B, Gill A
  
  
    Cureus
    . 2019 Jan;
          10(10):e3476.
    
    PMID: 30648027
  
  
          An 82-year-old male with benign prostatic hyperplasia (BPH) who underwent transurethral resection of the prostate (TURP) presented to the hospital with suprapubic pain, abdominal distension, and diarrhea. The physical examination...